In addition, co-transfection of miR-96 mimic and the PTPN9-overexpression plasmid markedly decreased the number of MCF-7 cells that passed through the transwell chamber (Fig. 8G and H), indicating that miR-96-resistant PTPN9 is sufficient to reverse the pro-invasion effect of miR-96 on breast cancer cells. Here, PTPN9 is linked to breast cancer.